Yong Jeong

Scopus著者プロファイル

ウェブサイトhttps://hyoka.ofc.kyushu-u.ac.jp/html/100023097_ja.html

h-index

年別の研究成果

フィンガープリント

Yong Jeongが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

76 学術誌
5 総説
3 レター
1 コメント/討論

In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2023–24 season: Comparison with the 2010–11 to 2022–23 seasons
Goto, T., Kawai, N., Bando, T., Sato, T., Tani, N., Chong, Y. & Ikematsu, H., 3月 2025, In: Journal of Infection and Chemotherapy. 31, 3, 102602.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
3 !!Link opens in a new tab 被引用数 (Scopus)
Strain-specific anti-RBD IgG antibody titers against the WT, XBB.1.5, JN.1, and KP.3 strains consistently correlate with neutralizing activity following SARS-CoV-2 XBB.1.5-adapted mRNA vaccination
Goto, T., Chong, Y., Sato, T., Tani, N., Saiki, S., Ishida, S., Kawai, N., Bando, T. & Ikematsu, H., 12月 2025, In: Journal of Infection and Chemotherapy. 31, 12, 102842.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications
Nakamura, K., Goto, T., Shiraishi, K., Yonekawa, A., Eriguchi, Y., Akashi, K., Shimono, N. & Chong, Y., 12月 2024, In: BMC Infectious Diseases. 24, 1, 736.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
6 !!Link opens in a new tab 被引用数 (Scopus)
Correlation of patient symptoms with SARS-CoV-2 Omicron variant viral loads in nasopharyngeal and saliva samples and their influence on the performance of rapid antigen testing
Shiraishi, K., Chong, Y., Goto, T., Ishimaru, T., Shimono, N., Ikematsu, H. & Akashi, K., 11月 2024, In: Microbiology spectrum. 12, 11, e00932-24.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2022–23 season: Comparison with the 2010–11 to 2019–20 seasons
Goto, T., Kawai, N., Bando, T., Tani, N., Chong, Y. & Ikematsu, H., 3月 2024, In: Journal of Infection and Chemotherapy. 30, 3, p. 266-270 5 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
3 !!Link opens in a new tab 被引用数 (Scopus)

鄭湧

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2023–24 season: Comparison with the 2010–11 to 2022–23 seasons

Strain-specific anti-RBD IgG antibody titers against the WT, XBB.1.5, JN.1, and KP.3 strains consistently correlate with neutralizing activity following SARS-CoV-2 XBB.1.5-adapted mRNA vaccination

Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications

Correlation of patient symptoms with SARS-CoV-2 Omicron variant viral loads in nasopharyngeal and saliva samples and their influence on the performance of rapid antigen testing

In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2022–23 season: Comparison with the 2010–11 to 2019–20 seasons

鄭 湧

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2023–24 season: Comparison with the 2010–11 to 2022–23 seasons

Strain-specific anti-RBD IgG antibody titers against the WT, XBB.1.5, JN.1, and KP.3 strains consistently correlate with neutralizing activity following SARS-CoV-2 XBB.1.5-adapted mRNA vaccination

Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications

Correlation of patient symptoms with SARS-CoV-2 Omicron variant viral loads in nasopharyngeal and saliva samples and their influence on the performance of rapid antigen testing

In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2022–23 season: Comparison with the 2010–11 to 2019–20 seasons

鄭湧

In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2023–24 season: Comparison with the 2010–11 to 2022–23 seasons

In vitro neuraminidase inhibitory concentrations (IC₅₀) of four neuraminidase inhibitors in the Japanese 2022–23 season: Comparison with the 2010–11 to 2019–20 seasons